CPT Changes
Current book and archives back to 2000 Easy-to-read online book format Linked to and from code details
learn more
6D71 Mild neurocognitive disorder International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 Mild neurocognitive disorder is characterized by mild impairment in one or more cognitive domains relative to that expected given the individual’s age and general premorbid level of cognitive functioning, which represents a decline from the individual’s previous level of functioning. Diagnosis is based on report from the patient, informant, or clinical observation, and is accompanied by objective evidence of impairment by quantified clinical assessment or standardized cognitive testing. Cognitive impairment is not severe enough to significantly interfere with an individual’s ability to perform activities related to personal, family, social, educational, and/or occupational functioning or other important functional areas. Cognitive impairment is not attributable to normal aging and may be static, progressive, or may resolve or improve depending on underlying cause or treatment. Cognitive impairment may be attributable to an underlying acquired disease of the nervous system, a trauma, an infection or other disease process affecting the brain, use of specific substances or medications, nutritional deficiency or exposure to toxins, or the etiology may be undetermined. The impairment is not due to current substance intoxication or withdrawal.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Has causing condition - a selection is required - multiple selections are allowed [select] 1C60 Human immunodeficiency virus disease associated with tuberculosis – 1C60.0 HIV disease clinical stage 1 associated with tuberculosis – 1C60.1 HIV disease clinical stage 2 associated with tuberculosis – 1C60.2 HIV disease clinical stage 3 associated with tuberculosis – 1C60.3 HIV disease clinical stage 4 associated with tuberculosis – 1C60.Z Human immunodeficiency virus disease associated with tuberculosis, clinical stage unspecified –– 1C60.30 Kaposi sarcoma associated with human immunodeficiency virus disease associated with tuberculosis –– 1C60.3Y Other specified HIV disease clinical stage 4 associated with tuberculosis –– 1C60.3Z HIV disease clinical stage 4 associated with tuberculosis, unspecified 1C61 Human immunodeficiency virus disease associated with malaria – 1C61.0 HIV disease clinical stage 1 associated with malaria – 1C61.1 HIV disease clinical stage 2 associated with malaria – 1C61.2 HIV disease clinical stage 3 associated with malaria – 1C61.3 HIV disease clinical stage 4 associated with malaria – 1C61.Z Human immunodeficiency virus disease associated with malaria, clinical stage unspecified –– 1C61.30 Kaposi sarcoma associated with human immunodeficiency virus disease associated with malaria –– 1C61.3Y Other specified HIV disease clinical stage 4 associated with malaria –– 1C61.3Z HIV disease clinical stage 4 associated with malaria, unspecified 1C62 Human immunodeficiency virus disease without mention of tuberculosis or malaria – 1C62.0 HIV disease clinical stage 1 without mention of tuberculosis or malaria – 1C62.1 HIV disease clinical stage 2 without mention of tuberculosis or malaria – 1C62.2 HIV disease clinical stage 3 without mention of tuberculosis or malaria – 1C62.3 HIV disease clinical stage 4 without mention of tuberculosis or malaria – 1C62.Z Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified –– 1C62.30 Kaposi sarcoma associated with human immunodeficiency virus disease without mention of tuberculosis or malaria –– 1C62.3Y Other specified HIV disease clinical stage 4 without mention of tuberculosis or malaria –– 1C62.3Z HIV disease clinical stage 4 without mention of tuberculosis or malaria, unspecified – 6C40 Disorders due to use of alcohol –– 6C40.0 Episode of harmful use of alcohol –– 6C40.1 Harmful pattern of use of alcohol –– 6C40.2 Alcohol dependence –– 6C40.3 Alcohol intoxication –– 6C40.4 Alcohol withdrawal –– 6C40.5 Alcohol-induced delirium –– 6C40.6 Alcohol-induced psychotic disorder –– 6C40.7 Certain specified alcohol-induced mental or behavioural disorders –– 6C40.Y Other specified disorders due to use of alcohol –– 6C40.Z Disorders due to use of alcohol, unspecified ––– 6C40.10 Harmful pattern of use of alcohol, episodic ––– 6C40.11 Harmful pattern of use of alcohol, continuous ––– 6C40.1Z Harmful pattern of use of alcohol, unspecified ––– 6C40.20 Alcohol dependence, current use, continuous ––– 6C40.21 Alcohol dependence, current use, episodic ––– 6C40.22 Alcohol dependence, early full remission ––– 6C40.23 Alcohol dependence, sustained partial remission ––– 6C40.24 Alcohol dependence, sustained full remission ––– 6C40.2Z Alcohol dependence, unspecified ––– 6C40.40 Alcohol withdrawal, uncomplicated ––– 6C40.41 Alcohol withdrawal with perceptual disturbances ––– 6C40.42 Alcohol withdrawal with seizures ––– 6C40.43 Alcohol withdrawal with perceptual disturbances and seizures ––– 6C40.4Z Alcohol withdrawal, unspecified ––– 6C40.60 Alcohol-induced psychotic disorder with hallucinations ––– 6C40.61 Alcohol-induced psychotic disorder with delusions ––– 6C40.62 Alcohol-induced psychotic disorder with mixed psychotic symptoms ––– 6C40.6Z Alcohol-induced psychotic disorder, unspecified ––– 6C40.70 Alcohol-induced mood disorder ––– 6C40.71 Alcohol-induced anxiety disorder – 6C41 Disorders due to use of cannabis –– 6C41.0 Episode of harmful use of cannabis –– 6C41.1 Harmful pattern of use of cannabis –– 6C41.2 Cannabis dependence –– 6C41.3 Cannabis intoxication –– 6C41.4 Cannabis withdrawal –– 6C41.5 Cannabis-induced delirium –– 6C41.6 Cannabis-induced psychotic disorder –– 6C41.7 Certain specified cannabis-induced mental or behavioural disorders –– 6C41.Y Other specified disorders due to use of cannabis –– 6C41.Z Disorders due to use of cannabis, unspecified ––– 6C41.10 Harmful pattern of use of cannabis, episodic ––– 6C41.11 Harmful pattern of use of cannabis, continuous ––– 6C41.1Z Harmful pattern of use of cannabis, unspecified ––– 6C41.20 Cannabis dependence, current use ––– 6C41.21 Cannabis dependence, early full remission ––– 6C41.22 Cannabis dependence, sustained partial remission ––– 6C41.23 Cannabis dependence, sustained full remission ––– 6C41.2Z Cannabis dependence, unspecified ––– 6C41.70 Cannabis-induced mood disorder ––– 6C41.71 Cannabis-induced anxiety disorder – 6C42 Disorders due to use of synthetic cannabinoids –– 6C42.0 Episode of harmful use of synthetic cannabinoids –– 6C42.1 Harmful pattern of use of synthetic cannabinoids –– 6C42.2 Synthetic cannabinoid dependence –– 6C42.3 Synthetic cannabinoid intoxication –– 6C42.4 Synthetic cannabinoid withdrawal –– 6C42.5 Synthetic cannabinoid-induced delirium –– 6C42.6 Synthetic cannabinoid-induced psychotic disorder –– 6C42.7 Certain specified synthetic cannabinoids-induced mental or behavioural disorders –– 6C42.Y Other specified disorders due to use of synthetic cannabinoids –– 6C42.Z Disorders due to use of synthetic cannabinoids, unspecified ––– 6C42.10 Harmful pattern of use of synthetic cannabinoids, episodic ––– 6C42.11 Harmful pattern of use of synthetic cannabinoids, continuous ––– 6C42.1Y Other specified harmful pattern of use of synthetic cannabinoids ––– 6C42.1Z Harmful pattern of use of synthetic cannabinoids, unspecified ––– 6C42.20 Synthetic cannabinoid dependence, current use ––– 6C42.21 Synthetic cannabinoid dependence, early full remission ––– 6C42.22 Synthetic cannabinoid dependence, sustained partial remission ––– 6C42.23 Synthetic cannabinoid dependence, sustained full remission ––– 6C42.2Y Other specified synthetic cannabinoid dependence ––– 6C42.2Z Synthetic cannabinoid dependence, unspecified ––– 6C42.70 Synthetic cannabinoid-induced mood disorder ––– 6C42.71 Synthetic cannabinoid-induced anxiety disorder – 6C43 Disorders due to use of opioids –– 6C43.0 Episode of harmful use of opioids –– 6C43.1 Harmful pattern of use of opioids –– 6C43.2 Opioid dependence –– 6C43.3 Opioid intoxication –– 6C43.4 Opioid withdrawal –– 6C43.5 Opioid-induced delirium –– 6C43.6 Opioid-induced psychotic disorder –– 6C43.7 Certain specified opioid-induced mental or behavioural disorders –– 6C43.Y Other specified disorders due to use of opioids –– 6C43.Z Disorders due to use of opioids, unspecified ––– 6C43.10 Harmful pattern of use of opioids, episodic ––– 6C43.11 Harmful pattern of use of opioids, continuous ––– 6C43.1Z Harmful pattern of use of opioids, unspecified ––– 6C43.20 Opioid dependence, current use ––– 6C43.21 Opioid dependence, early full remission ––– 6C43.22 Opioid dependence, sustained partial remission ––– 6C43.23 Opioid dependence, sustained full remission ––– 6C43.2Z Opioid dependence, unspecified ––– 6C43.70 Opioid-induced mood disorder ––– 6C43.71 Opioid-induced anxiety disorder – 6C44 Disorders due to use of sedatives, hypnotics or anxiolytics –– 6C44.0 Episode of harmful use of sedatives, hypnotics or anxiolytics –– 6C44.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics –– 6C44.2 Sedative, hypnotic or anxiolytic dependence –– 6C44.3 Sedative, hypnotic or anxiolytic intoxication –– 6C44.4 Sedative, hypnotic or anxiolytic withdrawal –– 6C44.5 Sedative, hypnotic or anxiolytic-induced delirium –– 6C44.6 Sedative, hypnotic or anxiolytic-induced psychotic disorder –– 6C44.7 Certain specified sedatives, hypnotics or anxiolytic-induced mental or behavioural disorders –– 6C44.Y Other specified disorders due to use of sedatives, hypnotics or anxiolytics –– 6C44.Z Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified ––– 6C44.10 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic ––– 6C44.11 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous ––– 6C44.1Z Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified ––– 6C44.20 Sedative, hypnotic or anxiolytic dependence, current use ––– 6C44.21 Sedative, hypnotic or anxiolytic dependence, early full remission ––– 6C44.22 Sedative, hypnotic or anxiolytic dependence, sustained partial remission ––– 6C44.23 Sedative, hypnotic or anxiolytic dependence, sustained full remission ––– 6C44.2Z Sedative, hypnotic or anxiolytic dependence, unspecified ––– 6C44.40 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated ––– 6C44.41 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances ––– 6C44.42 Sedative, hypnotic or anxiolytic withdrawal, with seizures ––– 6C44.43 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and seizures ––– 6C44.4Z Sedative, hypnotic or anxiolytic withdrawal, unspecified ––– 6C44.70 Sedative, hypnotic or anxiolytic-induced mood disorder ––– 6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder – 6C45 Disorders due to use of cocaine –– 6C45.0 Episode of harmful use of cocaine –– 6C45.1 Harmful pattern of use of cocaine –– 6C45.2 Cocaine dependence –– 6C45.3 Cocaine intoxication –– 6C45.4 Cocaine withdrawal –– 6C45.5 Cocaine-induced delirium –– 6C45.6 Cocaine-induced psychotic disorder –– 6C45.7 Certain specified cocaine-induced mental or behavioural disorders –– 6C45.Y Other specified disorders due to use of cocaine –– 6C45.Z Disorders due to use of cocaine, unspecified ––– 6C45.10 Harmful pattern of use of cocaine, episodic ––– 6C45.11 Harmful pattern of use of cocaine, continuous ––– 6C45.1Z Harmful pattern of use of cocaine, unspecified ––– 6C45.20 Cocaine dependence, current use ––– 6C45.21 Cocaine dependence, early full remission ––– 6C45.22 Cocaine dependence, sustained partial remission ––– 6C45.23 Cocaine dependence, sustained full remission ––– 6C45.2Z Cocaine dependence, unspecified ––– 6C45.60 Cocaine-induced psychotic disorder with hallucinations ––– 6C45.61 Cocaine-induced psychotic disorder with delusions ––– 6C45.62 Cocaine-induced psychotic disorder with mixed psychotic symptoms ––– 6C45.6Z Cocaine-induced psychotic disorder, unspecified ––– 6C45.70 Cocaine-induced mood disorder ––– 6C45.71 Cocaine-induced anxiety disorder ––– 6C45.72 Cocaine-induced obsessive-compulsive or related disorder ––– 6C45.73 Cocaine-induced impulse control disorder – 6C46 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone –– 6C46.0 Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone –– 6C46.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone –– 6C46.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone –– 6C46.3 Stimulant intoxication including amphetamines, methamphetamine or methcathinone –– 6C46.4 Stimulant withdrawal including amphetamines, methamphetamine or methcathinone –– 6C46.5 Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone –– 6C46.6 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone –– 6C46.7 Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone –– 6C46.Y Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone –– 6C46.Z Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified ––– 6C46.10 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, episodic ––– 6C46.11 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone, continuous ––– 6C46.1Z Harmful pattern of use of stimulants including amphetamines, methamphetamine and methcathinone, unspecified ––– 6C46.20 Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use ––– 6C46.21 Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission ––– 6C46.22 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission ––– 6C46.23 Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission ––– 6C46.2Z Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified ––– 6C46.60 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with hallucinations ––– 6C46.61 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone with delusions ––– 6C46.62 Stimulant-induced psychotic disorder including amphetamines but excluding caffeine or cocaine with mixed psychotic symptoms ––– 6C46.6Z Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone, unspecified ––– 6C46.70 Stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone ––– 6C46.71 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone ––– 6C46.72 Stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone ––– 6C46.73 Stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone – 6C47 Disorders due to use of synthetic cathinones –– 6C47.0 Episode of harmful use of synthetic cathinones –– 6C47.1 Harmful pattern of use of synthetic cathinones –– 6C47.2 Synthetic cathinone dependence –– 6C47.3 Synthetic cathinone intoxication –– 6C47.4 Synthetic cathinone withdrawal –– 6C47.5 Synthetic cathinone-induced delirium –– 6C47.6 Synthetic cathinone-induced psychotic disorder –– 6C47.7 Certain specified synthetic cathinone-induced mental or behavioural disorders –– 6C47.Y Other specified disorders due to use of synthetic cathinones –– 6C47.Z Disorders due to use of synthetic cathinones, unspecified ––– 6C47.10 Harmful pattern of use of synthetic cathinones, episodic ––– 6C47.11 Harmful use of synthetic cathinones, continuous ––– 6C47.1Y Other specified harmful pattern of use of synthetic cathinones ––– 6C47.1Z Harmful pattern of use of synthetic cathinones, unspecified ––– 6C47.20 Synthetic cathinone dependence, current use ––– 6C47.21 Synthetic cathinone dependence, early full remission ––– 6C47.22 Synthetic cathinone dependence, sustained partial remission ––– 6C47.23 Synthetic cathinone dependence, sustained full remission ––– 6C47.2Y Other specified synthetic cathinone dependence ––– 6C47.2Z Synthetic cathinone dependence, unspecified ––– 6C47.60 Synthetic cathinone-induced psychotic disorder with hallucinations ––– 6C47.61 Synthetic cathinone-induced psychotic disorder with delusions ––– 6C47.62 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms ––– 6C47.6Z Synthetic cathinone-induced psychotic disorder, unspecified ––– 6C47.70 Synthetic cathinone-induced mood disorder ––– 6C47.71 Synthetic cathinone-induced anxiety disorder ––– 6C47.72 Synthetic cathinone-induced obsessive-compulsive or related syndrome ––– 6C47.73 Synthetic cathinone-induced impulse control disorder – 6C48 Disorders due to use of caffeine –– 6C48.0 Episode of harmful use of caffeine –– 6C48.1 Harmful pattern of use of caffeine –– 6C48.2 Caffeine intoxication –– 6C48.3 Caffeine withdrawal –– 6C48.4 Certain specified caffeine-induced mental or behavioural disorders –– 6C48.Y Other specified disorders due to use of caffeine –– 6C48.Z Disorders due to use of caffeine, unspecified ––– 6C48.10 Harmful pattern of use of caffeine, episodic ––– 6C48.11 Harmful pattern of use of caffeine, continuous ––– 6C48.1Z Harmful pattern of use of caffeine, unspecified ––– 6C48.40 Caffeine-induced anxiety disorder – 6C49 Disorders due to use of hallucinogens –– 6C49.0 Episode of harmful use of hallucinogens –– 6C49.1 Harmful pattern of use of hallucinogens –– 6C49.2 Hallucinogen dependence –– 6C49.3 Hallucinogen intoxication –– 6C49.4 Hallucinogen-induced delirium –– 6C49.5 Hallucinogen-induced psychotic disorder –– 6C49.6 Certain specified hallucinogen-induced mental or behavioural disorders –– 6C49.Y Other specified disorders due to use of hallucinogens –– 6C49.Z Disorders due to use of hallucinogens, unspecified ––– 6C49.10 Harmful pattern of use of hallucinogens, episodic ––– 6C49.11 Harmful pattern of use of hallucinogens, continuous ––– 6C49.1Z Harmful pattern of use of hallucinogens, unspecified ––– 6C49.20 Hallucinogen dependence, current use ––– 6C49.21 Hallucinogen dependence, early full remission ––– 6C49.22 Hallucinogen dependence, sustained partial remission ––– 6C49.23 Hallucinogen dependence, sustained full remission ––– 6C49.2Z Hallucinogen dependence, unspecified ––– 6C49.60 Hallucinogen-induced mood disorder ––– 6C49.61 Hallucinogen-induced anxiety disorder – 6C4A Disorders due to use of nicotine –– 6C4A.0 Episode of harmful use of nicotine –– 6C4A.1 Harmful pattern of use of nicotine –– 6C4A.2 Nicotine dependence –– 6C4A.3 Nicotine intoxication –– 6C4A.4 Nicotine withdrawal –– 6C4A.Y Other specified disorders due to use of nicotine –– 6C4A.Z Disorders due to use of nicotine, unspecified ––– 6C4A.10 Harmful pattern of use of nicotine, episodic ––– 6C4A.11 Harmful pattern of use of nicotine, continuous ––– 6C4A.1Z Harmful pattern of use of nicotine, unspecified ––– 6C4A.20 Nicotine dependence, current use ––– 6C4A.21 Nicotine dependence, early full remission ––– 6C4A.22 Nicotine dependence, sustained partial remission ––– 6C4A.23 Nicotine dependence, sustained full remission ––– 6C4A.2Z Nicotine dependence, unspecified – 6C4B Disorders due to use of volatile inhalants –– 6C4B.0 Episode of harmful use of volatile inhalants –– 6C4B.1 Harmful pattern of use of volatile inhalants –– 6C4B.2 Volatile inhalant dependence –– 6C4B.3 Volatile inhalant intoxication –– 6C4B.4 Volatile inhalant withdrawal –– 6C4B.5 Volatile inhalant-induced delirium –– 6C4B.6 Volatile inhalant-induced psychotic disorder –– 6C4B.7 Certain specified volatile inhalants-induced mental or behavioural disorders –– 6C4B.Y Other specified disorders due to use of volatile inhalants –– 6C4B.Z Disorders due to use of volatile inhalants, unspecified ––– 6C4B.10 Harmful pattern of use of volatile inhalants, episodic ––– 6C4B.11 Harmful pattern of use of volatile inhalants, continuous ––– 6C4B.1Z Harmful pattern of use of volatile inhalants, unspecified ––– 6C4B.20 Volatile inhalant dependence, current use ––– 6C4B.21 Volatile inhalant dependence, early full remission ––– 6C4B.22 Volatile inhalant dependence, sustained partial remission ––– 6C4B.23 Volatile inhalant dependence, sustained full remission ––– 6C4B.2Z Volatile inhalant dependence, unspecified ––– 6C4B.70 Volatile inhalant-induced mood disorder ––– 6C4B.71 Volatile inhalant-induced anxiety disorder – 6C4C Disorders due to use of MDMA or related drugs, including MDA –– 6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA –– 6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA –– 6C4C.2 MDMA or related drug dependence, including MDA –– 6C4C.3 MDMA or related drug intoxication, including MDA –– 6C4C.4 MDMA or related drug withdrawal, including MDA –– 6C4C.5 MDMA or related drug-induced delirium, including MDA –– 6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA –– 6C4C.7 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA –– 6C4C.Y Other specified disorders due to use of MDMA or related drugs, including MDA –– 6C4C.Z Disorders due to use of MDMA or related drugs, including MDA, unspecified ––– 6C4C.10 Harmful use of MDMA or related drugs, including MDA, episodic ––– 6C4C.11 Harmful use of MDMA or related drugs, including MDA, continuous ––– 6C4C.1Z Harmful pattern of use of MDMA or related drugs, including MDA, unspecified ––– 6C4C.20 MDMA or related drug dependence, including MDA, current use ––– 6C4C.21 MDMA or related drug dependence, including MDA, early full remission ––– 6C4C.22 MDMA or related drug dependence, including MDA, sustained partial remission ––– 6C4C.23 MDMA or related drug dependence, including MDA, sustained full remission ––– 6C4C.2Z MDMA or related drug dependence, including MDA, unspecified ––– 6C4C.70 MDMA or related drug-induced mood disorder, including MDA ––– 6C4C.71 MDMA or related drug-induced anxiety disorder – 6C4D Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP] –– 6C4D.0 Episode of harmful use of dissociative drugs including ketamine or PCP –– 6C4D.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP –– 6C4D.2 Dissociative drug dependence including ketamine or PCP –– 6C4D.3 Dissociative drug intoxication including Ketamine or PCP –– 6C4D.4 Dissociative drug-induced delirium including ketamine or PCP –– 6C4D.5 Dissociative drug-induced psychotic disorder including Ketamine or PCP –– 6C4D.6 Certain specified dissociative drug-induced mental or behavioural disorders, including ketamine and phencyclidine [PCP] –– 6C4D.Y Other specified disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP] –– 6C4D.Z Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP], unspecified ––– 6C4D.10 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic ––– 6C4D.11 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous ––– 6C4D.1Z Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified ––– 6C4D.20 Dissociative drug dependence including Ketamine or PCP, current use ––– 6C4D.21 Dissociative drug dependence including ketamine or PCP, early full remission ––– 6C4D.22 Dissociative drug dependence including Ketamine or PCP, sustained partial remission ––– 6C4D.23 Dissociative drug dependence including Ketamine or PCP, sustained full remission ––– 6C4D.2Z Dissociative drug dependence including ketamine or PCP, unspecified ––– 6C4D.60 Dissociative drug-induced mood disorder including Ketamine or PCP ––– 6C4D.61 Dissociative drug-induced anxiety disorder including Ketamine or PCP – 6C4E Disorders due to use of other specified psychoactive substances, including medications –– 6C4E.0 Episode of harmful use of other specified psychoactive substance –– 6C4E.1 Harmful pattern of use of other specified psychoactive substance –– 6C4E.2 Other specified psychoactive substance dependence –– 6C4E.3 Other specified psychoactive substance intoxication –– 6C4E.4 Other specified psychoactive substance withdrawal –– 6C4E.5 Delirium induced by other specified psychoactive substance including medications –– 6C4E.6 Psychotic disorder induced by other specified psychoactive substance –– 6C4E.7 Certain other specified psychoactive substance-induced mental or behavioural disorders –– 6C4E.Y Other specified disorders due to use of other specified psychoactive substances, including medications –– 6C4E.Z Disorders due to use of other specified psychoactive substances, including medications, unspecified ––– 6C4E.10 Harmful pattern of use of other specified psychoactive substance, episodic ––– 6C4E.11 Harmful pattern of use of other specified psychoactive substance, continuous ––– 6C4E.1Z Harmful pattern of use of other specified psychoactive substance, unspecified ––– 6C4E.20 Other specified psychoactive substance dependence, current use ––– 6C4E.21 Other specified psychoactive substance dependence, early full remission ––– 6C4E.22 Other specified psychoactive substance dependence, sustained partial remission ––– 6C4E.23 Other specified psychoactive substance dependence, sustained full remission ––– 6C4E.2Z Other specified psychoactive substance dependence, unspecified ––– 6C4E.40 Other specified psychoactive substance withdrawal, uncomplicated ––– 6C4E.41 Other specified psychoactive substance withdrawal, with perceptual disturbances ––– 6C4E.42 Other specified psychoactive substance withdrawal, with seizures ––– 6C4E.43 Other specified psychoactive substance withdrawal, with perceptual disturbances and seizures ––– 6C4E.4Z Other specified psychoactive substance withdrawal, unspecified ––– 6C4E.70 Mood disorder induced by other specified psychoactive substance ––– 6C4E.71 Anxiety disorder induced by other specified psychoactive substance ––– 6C4E.72 Obsessive-compulsive or related disorder induced by other specified psychoactive substance ––– 6C4E.73 Impulse control disorder induced by other specified psychoactive substance – 6C4F Disorders due to use of multiple specified psychoactive substances, including medications –– 6C4F.0 Episode of harmful use of multiple specified psychoactive substances –– 6C4F.1 Harmful pattern of use of multiple specified psychoactive substances –– 6C4F.2 Multiple specified psychoactive substances dependence –– 6C4F.3 Intoxication due to multiple specified psychoactive substances –– 6C4F.4 Multiple specified psychoactive substances withdrawal –– 6C4F.5 Delirium induced by multiple specified psychoactive substances including medications –– 6C4F.6 Psychotic disorder induced by multiple specified psychoactive substances –– 6C4F.7 Certain multiple specified psychoactive substances-induced mental or behavioural disorders –– 6C4F.Y Other specified disorders due to use of multiple specified psychoactive substances, including medications –– 6C4F.Z Disorders due to use of multiple specified psychoactive substances, including medications, unspecified ––– 6C4F.10 Harmful pattern of use of multiple specified psychoactive substances, episodic ––– 6C4F.11 Harmful pattern of use of multiple specified psychoactive substances, continuous ––– 6C4F.1Z Harmful pattern of use of multiple specified psychoactive substances, unspecified ––– 6C4F.20 Multiple specified psychoactive substances dependence, current use ––– 6C4F.21 Multiple specified psychoactive substances dependence, early full remission ––– 6C4F.22 Multiple specified psychoactive substances dependence, sustained partial remission ––– 6C4F.23 Multiple specified psychoactive substances dependence, sustained full remission ––– 6C4F.2Z Multiple specified psychoactive substances dependence, unspecified ––– 6C4F.40 Multiple specified psychoactive substances withdrawal, uncomplicated ––– 6C4F.41 Multiple specified psychoactive substances withdrawal, with perceptual disturbances ––– 6C4F.42 Multiple specified psychoactive substances withdrawal, with seizures ––– 6C4F.43 Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures ––– 6C4F.4Y Other specified multiple specified psychoactive substances withdrawal ––– 6C4F.4Z Multiple specified psychoactive substances withdrawal, unspecified ––– 6C4F.70 Mood disorder induced by multiple specified psychoactive substances ––– 6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances ––– 6C4F.72 Obsessive-compulsive or related disorder induced by multiple specified psychoactive substances ––– 6C4F.73 Impulse control syndrome induced by multiple specified psychoactive substances – 6C4G Disorders due to use of unknown or unspecified psychoactive substances –– 6C4G.0 Episode of harmful use of unknown or unspecified psychoactive substances –– 6C4G.1 Harmful pattern of use of unknown or unspecified psychoactive substance –– 6C4G.2 Unknown or unspecified psychoactive substance dependence –– 6C4G.3 Intoxication due to unknown or unspecified psychoactive substance –– 6C4G.4 Withdrawal due to unknown or unspecified psychoactive substance –– 6C4G.5 Delirium induced by unknown or unspecified psychoactive substance –– 6C4G.6 Psychotic disorder induced by unknown or unspecified psychoactive substance –– 6C4G.7 Certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders –– 6C4G.Y Other specified disorders due to use of unknown or unspecified psychoactive substances –– 6C4G.Z Disorders due to use of unknown or unspecified psychoactive substances, unspecified ––– 6C4G.10 Harmful pattern of use of unknown or unspecified psychoactive substance, episodic ––– 6C4G.11 Harmful pattern of use of unknown or unspecified psychoactive substance, continuous ––– 6C4G.1Z Harmful pattern of use of unknown or unspecified psychoactive substance, unspecified ––– 6C4G.20 Unknown or unspecified psychoactive substance dependence, current use ––– 6C4G.21 Unknown or unspecified psychoactive substance dependence, early full remission ––– 6C4G.22 Unknown or unspecified psychoactive substance dependence, sustained partial remission ––– 6C4G.23 Unknown or unspecified psychoactive substance dependence, sustained full remission ––– 6C4G.2Z Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified ––– 6C4G.40 Withdrawal due to unknown or unspecified psychoactive substance, uncomplicated ––– 6C4G.41 Withdrawal due to unknown or unspecified psychoactive substance, with perceptual disturbances ––– 6C4G.42 Withdrawal due to unknown or unspecified psychoactive substance, with seizures ––– 6C4G.43 Withdrawal due to unknown or unspecified psychoactive, with perceptual disturbances and seizures ––– 6C4G.4Z Withdrawal due to unknown or unspecified psychoactive substance, unspecified ––– 6C4G.70 Mood disorder induced by unknown or unspecified psychoactive substance ––– 6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substance ––– 6C4G.72 Obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance ––– 6C4G.73 Impulse control disorder induced by unknown or unspecified psychoactive substance – 6C4H Disorders due to use of non-psychoactive substances –– 6C4H.0 Episode of harmful use of non-psychoactive substances –– 6C4H.1 Harmful pattern of use of non-psychoactive substances –– 6C4H.Y Other specified disorders due to use of non-psychoactive substances –– 6C4H.Z Disorders due to use of non-psychoactive substances, unspecified ––– 6C4H.10 Harmful pattern of use of non-psychoactive substances, episodic ––– 6C4H.11 Harmful pattern of use of non-psychoactive substances, continuous ––– 6C4H.1Z Harmful pattern of use of non-psychoactive substances, unspecified – 6C4Y Other specified disorders due to substance use – 6C4Z Disorders due to substance use, unspecified – 8A00.0 Parkinson disease –– 8A00.00 Sporadic Parkinson disease –– 8A00.01 Familial Parkinson disease –– 8A00.0Y Other specified Parkinson disease –– 8A00.0Z Parkinson disease, unspecified –– 8A01.10 Huntington disease 8A20 Alzheimer disease 8A22 Lewy body disease 8A23 Frontotemporal lobar degeneration 8A40 Multiple sclerosis – 8A40.0 Relapsing-remitting multiple sclerosis – 8A40.1 Primary progressive multiple sclerosis – 8A40.2 Secondary progressive multiple sclerosis – 8A40.Y Other specified multiple sclerosis – 8A40.Z Multiple sclerosis, unspecified – 8B00 Intracerebral haemorrhage –– 8B00.0 Deep hemispheric haemorrhage –– 8B00.1 Lobar haemorrhage –– 8B00.2 Brainstem haemorrhage –– 8B00.3 Cerebellar haemorrhage –– 8B00.4 Intraventricular haemorrhage without parenchymal haemorrhage –– 8B00.5 Haemorrhage of multiple sites –– 8B00.Z Intracerebral haemorrhage, site unspecified – 8B01 Subarachnoid haemorrhage –– 8B01.0 Aneurysmal subarachnoid haemorrhage –– 8B01.1 Non-aneurysmal subarachnoid haemorrhage –– 8B01.2 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal – 8B02 Nontraumatic subdural haemorrhage – 8B03 Nontraumatic epidural haemorrhage – 8B0Z Intracranial haemorrhage, unspecified – 8B10 Transient ischaemic attack –– 8B10.0 Amaurosis fugax –– 8B10.Y Other specified transient ischaemic attack –– 8B10.Z Transient ischaemic attack, unspecified – 8B11 Cerebral ischaemic stroke –– 8B11.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis –– 8B11.1 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis –– 8B11.2 Cerebral ischaemic stroke due to embolic occlusion –– 8B11.3 Cerebral ischaemic stroke due to small artery occlusion –– 8B11.4 Cerebral ischaemic stroke due to other known cause –– 8B11.5 Cerebral ischaemic stroke of unknown cause ––– 8B11.20 Cerebral ischaemic stroke due to cardiac embolism ––– 8B11.21 Cerebral ischaemic stroke due to aortic arch embolism ––– 8B11.22 Cerebral ischaemic stroke due to paradoxical embolism ––– 8B11.2Y Cerebral ischaemic stroke due to other specified embolic occlusion ––– 8B11.2Z Cerebral ischaemic stroke due to embolic occlusion, unspecified ––– 8B11.40 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct ––– 8B11.41 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy ––– 8B11.42 Cerebral ischaemic stroke due to hypercoagulable state ––– 8B11.43 Cerebral ischaemic stroke in association with subarachnoid haemorrhage ––– 8B11.44 Cerebral ischemic stroke from dissection ––– 8B11.50 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery ––– 8B11.51 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery ––– 8B11.5Z Cerebral ischaemic stroke, unspecified – 8B1Y Other specified cerebral ischaemia – 8B1Z Cerebral ischaemia, unspecified 8B20 Stroke not known if ischaemic or haemorrhagic 8B21 Cerebrovascular disease with no acute cerebral symptom – 8B21.0 Silent cerebral infarct – 8B21.1 Silent cerebral microbleed – 8B21.Y Other specified cerebrovascular disease with no acute cerebral symptom – 8B21.Z Cerebrovascular disease with no acute cerebral symptom, unspecified 8B22 Certain specified cerebrovascular diseases – 8B22.0 Dissection of cerebral arteries – 8B22.1 Cerebral venous thrombosis – 8B22.2 Cerebral vasoconstriction syndromes – 8B22.3 Isolated cerebral amyloid angiopathy – 8B22.4 Intracranial vascular malformation – 8B22.5 Cerebral aneurysm, nonruptured – 8B22.6 Familial cerebral saccular aneurysm – 8B22.7 Cerebral arteritis, not elsewhere classified – 8B22.8 Hypertensive encephalopathy – 8B22.9 Migraine-induced stroke – 8B22.A Subclavian steal syndrome – 8B22.B Moyamoya syndrome – 8B22.C Hereditary cerebrovascular diseases – 8B22.Y Other specified cerebrovascular disease –– 8B22.40 Arteriovenous malformation of cerebral vessels –– 8B22.41 Cerebral cavernous malformation –– 8B22.42 Dural arteriovenous fistula –– 8B22.43 Carotid cavernous fistula –– 8B22.4Y Other specified intracranial vascular malformation –– 8B22.4Z Intracranial vascular malformation, unspecified –– 8B22.70 Primary cerebral arteritis –– 8B22.7Y Other specified cerebral arteritis, not elsewhere classified –– 8B22.7Z Cerebral arteritis, not elsewhere classified, unspecified –– 8B22.C0 CADASIL - [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome –– 8B22.C1 CARASIL - [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome –– 8B22.CY Other specified hereditary cerebrovascular diseases –– 8B22.CZ Hereditary cerebrovascular diseases, unspecified 8B23 Cerebrovascular abnormalities 8B24 Hypoxic-ischaemic encephalopathy – 8B24.0 Anoxic-ischaemic encephalopathy – 8B24.Y Other specified hypoxic-ischaemic encephalopathy – 8B24.Z Hypoxic-ischaemic encephalopathy, unspecified 8B25 Late effects of cerebrovascular disease – 8B25.0 Late effects of cerebral ischemic stroke – 8B25.1 Late effects of intracerebral haemorrhage – 8B25.2 Late effects of subarachnoid haemorrhage – 8B25.3 Late effects of other nontraumatic intracranial haemorrhage – 8B25.4 Late effects of stroke not known if ischaemic or haemorrhagic – 8B25.Y Late effects of other specified cerebrovascular disease – 8B25.Z Late effects of cerebrovascular disease, unspecified 8B26 Vascular syndromes of brain in cerebrovascular diseases – 8B26.0 Brainstem stroke syndrome – 8B26.1 Cerebellar stroke syndrome – 8B26.2 Middle cerebral artery syndrome – 8B26.3 Anterior cerebral artery syndrome – 8B26.4 Posterior cerebral artery syndrome – 8B26.5 Lacunar syndromes – 8B26.Y Other specified vascular syndromes of brain in cerebrovascular diseases – 8B26.Z Vascular syndromes of brain in cerebrovascular diseases, unspecified –– 8B26.50 Pure motor lacunar syndrome –– 8B26.51 Pure sensory lacunar syndrome –– 8B26.5Y Other specified lacunar syndromes –– 8B26.5Z Lacunar syndromes, unspecified 8B2Z Cerebrovascular diseases, unspecified –– 8D64.04 Normal-pressure hydrocephalus 8E00 Sporadic Creutzfeldt-Jakob Disease 8E01 Acquired prion disease – 8E01.0 Iatrogenically acquired Creutzfeldt-Jakob Disease – 8E01.1 Kuru – 8E01.2 Variant Creutzfeldt-Jakob Disease – 8E01.3 Other acquired Creutzfeldt-Jakob Disease – 8E01.Z Acquired prion disease, unspecified 8E02 Genetic prion diseases – 8E02.0 Genetic Creutzfeldt-Jakob disease – 8E02.1 Gerstmann-Straussler-Scheinker syndrome – 8E02.2 Fatal familial insomnia – 8E02.3 Other genetic prion diseases – 8E02.Y Other specified Creutzfeldt-Jakob disease – 8E02.Z Creutzfeldt-Jakob disease, unspecified 8E03 Variably protease sensitive prionopathy 8E0Y Other specified human prion diseases 8E0Z Human prion diseases, unspecified – LD40.0 Complete trisomy 21 NA07 Intracranial injury – NA07.0 Concussion – NA07.1 Traumatic intracerebral haemorrhage – NA07.2 Traumatic cerebral oedema – NA07.3 Diffuse brain injury – NA07.4 Focal brain injury – NA07.5 Traumatic epidural haemorrhage – NA07.6 Traumatic subdural haemorrhage – NA07.7 Traumatic subarachnoid haemorrhage – NA07.8 Traumatic haemorrhage in brain tissue – NA07.Y Other specified intracranial injury – NA07.Z Intracranial injury, unspecified –– NA07.00 Concussion with incomplete loss of consciousness with amnesia –– NA07.01 Concussion with incomplete loss of consciousness without amnesia –– NA07.02 Concussion with loss of consciousness, short duration of less than 30 minutes –– NA07.03 Concussion with loss of consciousness, short duration of 30 minutes to less than one hour –– NA07.04 Concussion with loss of consciousness, short duration of one hour to less than 6 hours –– NA07.05 Concussion with loss of consciousness, intermediate duration of 6 hours to less than 24 hours –– NA07.06 Concussion with loss of consciousness, persisting longer than 24 hours or until discharge or latest assessment –– NA07.07 Concussion with loss of consciousness, persisting until death –– NA07.08 Concussion with loss of consciousness, duration unspecified or unknown due to effects of therapy –– NA07.09 Concussion with loss of consciousness, duration unspecified or unknown due to lack of information –– NA07.0Y Other specified concussion –– NA07.0Z Concussion, unspecified –– NA07.20 Diffuse traumatic cerebral oedema –– NA07.21 Focal traumatic cerebral oedema –– NA07.2Y Other specified traumatic cerebral oedema –– NA07.2Z Traumatic cerebral oedema, unspecified –– NA07.30 Diffuse injury of cerebrum –– NA07.31 Diffuse injury of cerebellum –– NA07.32 Diffuse injury of brainstem –– NA07.33 Diffuse injury of multiple parts of brain –– NA07.3Y Other specified diffuse brain injury –– NA07.3Z Unspecified diffuse traumatic brain injury –– NA07.40 Focal non-haemorrhagic contusion of cerebrum –– NA07.41 Focal haemorrhagic contusion of cerebrum –– NA07.42 Focal laceration of cerebrum –– NA07.43 Multiple focal injuries of cerebrum –– NA07.44 Focal non-haemorrhagic contusion of cerebellum –– NA07.45 Focal haematoma or haemorrhage of cerebellum –– NA07.46 Focal laceration of cerebellum –– NA07.47 Multiple focal injuries of cerebellum –– NA07.48 Focal non-haemorrhagic contusion of brainstem –– NA07.49 Focal haematoma or haemorrhage of brainstem –– NA07.4A Contusion of temporal lobe –– NA07.4B Focal laceration of brainstem –– NA07.4C Focal brain contusion –– NA07.4D Focal brain laceration –– NA07.4E Contusion of parietal lobe –– NA07.4F Contusion of occipital lobe –– NA07.4Z Unspecified focal traumatic brain injury –– NA07.60 Acute traumatic subdural haemorrhage –– NA07.61 Chronic traumatic subdural haemorrhage –– NA07.6Z Traumatic subdural haemorrhage, unspecified whether acute or chronic –– NA07.80 Traumatic haemorrhage in cerebrum white matter –– NA07.81 Traumatic haemorrhage in thalamus or basal ganglia –– NA07.82 Traumatic haemorrhage in cerebellum –– NA07.83 Traumatic haemorrhage in brainstem without specification whether primary or secondary –– NA07.84 Traumatic haemorrhage in brainstem, primary –– NA07.85 Traumatic haemorrhage in brainstem, secondary –– NA07.86 Multiple traumatic haemorrhages –– NA07.8Y Other specified traumatic haemorrhage in brain tissue –– NA07.8Z Traumatic haemorrhage in brain tissue, unspecified NE61 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified
synonyms Mild neurocognitive disorder minor neurocognitive disorder Postconcussional syndrome post-concussion syndrome post-concussional syndrome post-contusional encephalopathy post-contusional syndrome post-traumatic brain syndrome postconcussion syndrome postcontusional syndrome postconcussional disorder concussion syndrome nonpsychotic post-traumatic brain syndrome post-traumatic organic brain syndrome punch drunk status postcommotio cerebri post-traumatic dementia Postcontusional encephalopathy Mild cognitive impairment Mild lack of memory following organic brain damage Mild memory disorder following organic brain damage Mild memory disturbance following organic brain damage Mild memory loss following organic brain damage
Thank you for choosing Find-A-Code, please Sign In to remove ads.